Fintel reports that on December 15, 2025, HC Wainwright & Co. maintained coverage of ACADIA Pharmaceuticals (NasdaqGS:ACAD) with a Buy recommendation. Analyst Price Forecast Suggests 9.94% Upside As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback